Lynx Investment Advisory West Pharmaceutical Services Inc Transaction History
Lynx Investment Advisory
- $135 Billion
- Q2 2024
A detailed history of Lynx Investment Advisory transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Lynx Investment Advisory holds 261 shares of WST stock, worth $80,369. This represents 0.06% of its overall portfolio holdings.
Number of Shares
261Holding current value
$80,369% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding WST
# of Institutions
834Shares Held
64.8MCall Options Held
345KPut Options Held
211K-
Vanguard Group Inc Valley Forge, PA8.94MShares$2.75 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY7.58MShares$2.33 Billion0.06% of portfolio
-
State Street Corp Boston, MA3.2MShares$987 Million0.05% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.49MShares$767 Million1.3% of portfolio
-
Franklin Resources Inc San Mateo, CA2.47MShares$760 Million0.26% of portfolio
About WEST PHARMACEUTICAL SERVICES INC
- Ticker WST
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,033,000
- Market Cap $22.8B
- Description
- West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...